NPJ5008 for treating malignant hyperthermia


featured image

Dantrolene sodium is a muscle relaxant drug that is used for the treatment of malignant hyperthermia (MH). An improved formulation of dantrolene sodium (NPJ5008) is currently in development.

Interventions: NPJ5008
Indications: Malignant hyperthermia
Therapeutic Areas: Genetic Disorders
Year: 2022

Dantrolene sodium is a muscle relaxant drug that is used for the treatment of malignant hyperthermia (MH). An improved formulation of dantrolene sodium (NPJ5008) is currently in development. MH is a rare life-threatening condition triggered by general anaesthetic drugs used in surgery. MH is more common in males, or those who have had a close relative experience the condition, but can occur in anyone, with nearly half of reported MH cases being in children. MH symptoms include high body temperature, elevated carbon dioxide levels, sustained muscle contractions, and can result in death if not treated quickly. There are currently no NICE recommended treatments for MH. Faster delivery of medication to patients with MH have been shown to reduce mortality